Article
Se-Glargine II. Native Function of a Basal Insulin Analog Stabilized by an Internal Diselenide Bridge
2023-06-24
Abstract excerpt
Insulin glargine, the active component of basal clinical pharmaceutical formulations Lantus® and Toujeo® (Sanofi), provides a model for principles of therapeutic protein design. Formulated in solution at pH 4, insulin glargine exhibits a shifted isoelectric point (from pH 5.3 to neutral pH) due to a basic dipeptide B-chain extension (Arg B31 -Arg B32 ). In the first article in this series, we described pairwise...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5a2a09e6-a25e-5bbb-977c-3c1223c13938
- DOI
- 10.1101/2023.06.24.546337
